Chief Healthcare Executive November 16, 2024
The federal government said it will allow remote prescriptions of controlled substances to continue. Health advocacy groups urged federal officials for an extension.
While healthcare advocacy groups continue to press for telehealth reforms, they scored one important victory Friday.
The federal government has agreed to a one-year extension for telehealth prescriptions of certain controlled substances. The notice is slated to appear in the Federal Register next week.
The waivers for telehealth prescriptions were set to expire at the end of the year, and telehealth providers and supporters had grown increasingly anxious about an extension. With the extension, providers will be allowed to continue remote prescriptions of certain controlled substances, such as Oxycontin and Xanax, through 2025. Healthcare trade groups had...
Today's Sponsors
Today's Sponsor